The Fed is expected to cut rates in October with a focus on QT policy as liquidity remains stable. Learn why QT may run ...
The U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib), which is a menin inhibitor, for the treatment ...
An artificial intelligence algorithm is able to identify patients with congenital Long QT syndrome using limited electrocardiogram data, according to an abstract published May 10 at the Heart Rhythm ...
Please provide your email address to receive an email when new articles are posted on . BOSTON — Artificial intelligence using deep neural networks identified patients with congenital long QT syndrome ...
Copenhagen, Denmark - A team of Danish researchers have shown that certain patients with congestive heart failure (CHF) may benefit from the class III antiarrhythmic drug dofetilide (Tikosyn? - Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results